Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, et al.
Psychopharmacology (2023) Vol. 240, Iss. 7, pp. 1547-1560
Open Access | Times Cited: 18

Showing 18 citing articles:

At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
David S. Mathai, Thomas D. Hull, Leonardo Vando, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 198-208
Open Access | Times Cited: 6
The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1494-1494
Open Access | Times Cited: 11
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Inside the Journey: A Qualitative Study of Intravenous Ketamine Therapy for Treatment-Resistant Depression in Canada
Jason Perepelkin, Polixeni Hantjidis, Kristopher K. Robison, et al.
Journal of Affective Disorders Reports (2025), pp. 100886-100886
Open Access
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience)
Marco Di Nicola, Maria Pepe, Giacomo d’Andrea, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 161-161
Open Access
‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change
Rúna F. E. Walther, Hein T. van Schie
Psychoactives (2024) Vol. 3, Iss. 3, pp. 411-436
Open Access | Times Cited: 3
Enhancing Agency in Posttraumatic Stress Disorder Therapies Through Sensorimotor Technologies
Vladimir Adrien, Nicolas Bosc, Claire Peccia Galletto, et al.
Journal of Medical Internet Research (2024) Vol. 26, pp. e58390-e58390
Open Access | Times Cited: 2
Learning how to make use of dissociative therapies
David S. Mathai
International Review of Psychiatry (2024), pp. 1-13
Closed Access | Times Cited: 2
Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect
Hugo Bottemanne, Lucie Berkovitch, Christophe Gauld, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 154, pp. 105410-105410
Open Access | Times Cited: 5
Overcoming the myths of esketamine administration: different and not difficult
Florian Buchmayer, Siegfried Kasper
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers
David S. Mathai, Samantha Hilbert, Nathan D. Sepeda, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 241-252
Closed Access | Times Cited: 4
Patient and provider perspectives on the phenomenon and effective treatment of treatment-resistant depression: A grounded theory
Aubrey Bornhoff, Edward B. Davis, Jonathon Yousey, et al.
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100779-100779
Open Access | Times Cited: 1
A Psychometric Evaluation of the Dutch Revised Mystical Experience Questionnaire
A. Wirsching, Tijmen Bostoen, Anja C. Huizink
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 5, pp. 637-647
Open Access | Times Cited: 2
Exploring inner depths
Joost Breeksema
(2024)
Open Access
Enhancing Agency in Posttraumatic Stress Disorder Therapies Through Sensorimotor Technologies (Preprint)
Vladimir Adrien, Nicolas Bosc, Claire Peccia Galletto, et al.
(2024)
Open Access
Ketamine and Esketamine
David S. Mathai, Sanjay J. Mathew
American Psychiatric Association Publishing eBooks (2024)
Closed Access
How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta‐Synthesis of Qualitative Studies
Melanie Trimmel, Antonia Renner, Alexander Kaltenboeck
International Journal of Mental Health Nursing (2024)
Open Access
Patient experiences of treatment-resistant depression (TRD): A systematic review and qualitative meta-synthesis
Alexandra Cernat, Manisha Pahwa, Dima Hadid, et al.
PLOS mental health. (2024) Vol. 1, Iss. 6, pp. e0000128-e0000128
Open Access
Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review
Ana Sousa Ferreira, Paulo Reis-Pina
Journal of Psychosomatic Research (2024) Vol. 189, pp. 112020-112020
Open Access
Page 1

Scroll to top